XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Shareholders' Deficit - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Paid-in Capital
(Deficit)
(Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss, Net
Balance as of beginning period (in shares) at Dec. 26, 2018     108,585,000          
Balance as of beginning period at Dec. 26, 2018 $ (133,345) $ (394) $ 1,086 $ (416,815) $ 592,944 $ (306,414) $ (394) $ (4,146)
Balance as of beginning of period, treasury stock (in shares) at Dec. 26, 2018       (47,052,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 117,410         117,410    
Other comprehensive income (29,814)             (29,814)
Share-based compensation on equity classified awards, net 3,310       3,310      
Purchase of treasury stock (in shares)       (4,879,000)        
Purchase of treasury stock (96,202)     $ (96,202)        
Equity forward contract settlement (in shares)       (389,000)        
Equity forward contract settlement 0     $ (6,763) 6,763      
Issuance of common stock for share-based compensation (in shares)     468,000          
Issuance of common stock for share-based compensation 0   $ 5   (5)      
Exercise of common stock options (in shares)     362,000          
Exercise of common stock options 971   $ 3   968      
Balance as of end of period (in shares) at Dec. 25, 2019     109,415,000          
Balance as of end of period at Dec. 25, 2019 (138,064)   $ 1,094 $ (519,780) 603,980 (189,398)   (33,960)
Balance as of end of period, treasury stock (in shares) at Dec. 25, 2019       (52,320,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (5,116)         (5,116)    
Other comprehensive income (26,445)             (26,445)
Share-based compensation on equity classified awards, net $ 3,374       3,374      
Purchase of treasury stock (in shares) (1,700,000)     (1,690,000)        
Purchase of treasury stock $ (34,193)     $ (34,193)        
Issuance of common stock (in shares)     8,000,000          
Issuance of common stock 69,571   $ 80   69,491      
Retirement of shares (in shares)     (54,010,000) 54,010,000        
Retirement of treasury stock 0   $ (540) $ 553,973 (553,433)      
Issuance of common stock for share-based compensation (in shares)     447,000          
Issuance of common stock for share-based compensation 0   $ 5   (5)      
Exercise of common stock options (in shares)     110,000          
Exercise of common stock options $ 427   $ 1   426      
Balance as of end of period (in shares) at Dec. 30, 2020 63,962,000   63,962,000          
Balance as of end of period at Dec. 30, 2020 $ (130,446)   $ 640 $ 0 123,833 (194,514)   (60,405)
Balance as of end of period, treasury stock (in shares) at Dec. 30, 2020 0     0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) $ 78,073         78,073    
Other comprehensive income 5,935             5,935
Share-based compensation on equity classified awards, net $ 11,649       11,649      
Purchase of treasury stock (in shares) (2,000,000)     (1,990,000)        
Purchase of treasury stock $ (30,592)     $ (30,592)        
Issuance of common stock for share-based compensation (in shares)     208,000          
Issuance of common stock for share-based compensation 0   $ 2   (2)      
Exercise of common stock options (in shares)     30,000          
Exercise of common stock options $ 116   $ 0   116      
Balance as of end of period (in shares) at Dec. 29, 2021 64,200,000   64,200,000          
Balance as of end of period at Dec. 29, 2021 $ (65,265)   $ 642 $ (30,592) $ 135,596 $ (116,441)   $ (54,470)
Balance as of end of period, treasury stock (in shares) at Dec. 29, 2021 (1,990,000)     (1,990,000)